Antiapoptotic effect of dipyrone on HL-60, Jurkat and Raji cell lines submitted to UV irradiation, arachidonic acid and cycloheximide treatments

被引:26
作者
Pompeia, C
Boaventura, MFC
Curi, R
机构
[1] Natl Inst Deafness & Other Commun Disorders, Natl Inst Hlth USA, Bethesda, MD 20892 USA
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Lab Cell Physiol, BR-05508900 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
dipyrone; metamizol; leukocytes; apoptosis; antiapoptotic effect; cytoprotection;
D O I
10.1016/S1567-5769(01)00144-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of dipyrone (metamizol) on cell viability was evaluated in human leukocyte cell lines upon different apoptotic treatments: arachidonic acid (AA), cycloheximide (CHX), tumor necrosis factor (TNF) and ultraviolet (UV) irradiation, Dipyrone had a dual effect: at high concentrations (beyond 300 muM), it was cytotoxic, leading to apoptosis, whereas at lower concentrations (37.5-300 muM), it was cytoprotective, delaying the loss of membrane integrity triggered by arachidonic acid (100-200 muM) and UV irradiation and the cytotoxicity of cycloheximide (25-50 muM). No effect of dipyrone was found on TNF-induced cytotoxicity (250 ng/ml). The cytoprotective effect of dipyrone is associated with a decrease in DNA fragmentation, as assessed by electrophoresis of genomic DNA and by flow cytometry; a reduction in the percentage of condensed nuclei, as evaluated by DNA staining with Hoescht 33342 and a decrease in poly(ADP)-ribose polymerase (PARP) cleavage, as assessed by Western blotting. The cytoprotective effect of dipyrone on leukocyte apoptosis occurs at concentrations usually found for the main active metabolite of the drug and may have implications on the therapeutic and side effects caused by this agent. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:2173 / 2182
页数:10
相关论文
共 15 条
[1]   Mechanisms of cycloheximide-induced apoptosis in liver cells [J].
Alessenko, AV ;
Boikov, PY ;
Filippova, GN ;
Khrenov, AV ;
Loginov, AS ;
Makarieva, ED .
FEBS LETTERS, 1997, 416 (01) :113-116
[2]  
[Anonymous], 1989, SYNTHETIC OLIGONUCLE
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
CAMPOS DI, 1998, BRAZ J MED BIOL RES, V21, P565
[5]   ANALGESIA BY DIRECT ANTAGONISM OF NOCICEPTOR SENSITIZATION INVOLVES THE ARGININE-NITRIC OXIDE-CGMP PATHWAY [J].
DUARTE, IDG ;
DOSSANTOS, IR ;
LORENZETTI, BB ;
FERREIRA, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 217 (2-3) :225-227
[6]  
GONG JP, 1993, J CELL PHYSIOL, V157, P263
[7]  
INSEL PA, 1996, GOODMAN GILMANS PHAR, P642
[8]   CLINICAL PHARMACOKINETICS OF DIPYRONE AND ITS METABOLITES [J].
LEVY, M ;
ZYLBERKATZ, E ;
ROSENKRANZ, B .
CLINICAL PHARMACOKINETICS, 1995, 28 (03) :216-234
[9]   Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia [J].
Lorenzetti, BB ;
Ferreira, SH .
INFLAMMATION RESEARCH, 1996, 45 (06) :308-311
[10]  
LUTHY C, 1983, BRIT J PHARMACOL, V79, P849